Unpacking issues of adherence: moving beyond access
Download this report
If you would like to obtain a copy of this Research Output, please contact Hanlie Baudin at email@example.com.
With HIV/AIDS being recognised as a chronic disease, the success of treatment depends on at least 95% adherence rates. In addition, as efforts are implemented to improve comprehensive access to care, treatment and management of the disease, factors influencing adherence play a crucial role in preventing drug resistance. One of the objectives of an overall study on ARV delivery models in SA was to understand factors influencing adherence to ARVs, in urban as well as resource poor settings. Different tools to measure adherence on patients who have been on ARVs for a minimum of 6 months was aimed at providing empirical evidence on the extent of adherence problems through population data (quantitative); as well as why patients may not adhere (qualitative). Medication adherence is measured by patients themselves, through the method of 4 day dosing recall, including possible reasons as to why a dose may have been missed. Semi-structured questionnaires were used to explore other indirect factors which could influence adherence rates negatively. From the patient perspective, these factors range from socio-demographic profiles, alcohol and drug use, waiting times, level of social support, cost to access care and treatment, to clinical biomarkers providing a comprehensive medical history of individual patients, including first line and second line treatment regimes. From the provider perspective, the level of resources available as well as strategies adopted for patient monitoring is assessed. Human resource capacity is assessed in each facility - especially the availability of pharmacists and counsellors who are critical in adherence counselling, patient monitoring and quality service - while lack of adequate physical space would compromise confidentiality and deter patients from adequate follow-up. In SA, where ARVs are free at point of access, cost to both the provider as well as the patient to access continued care, provide further challenges in ensuring long term treatment and management of the disease.
Results of this study, show a 97.5% level of adherence to ARV medication. This is further supported by a mean improvement in CD4 count from 128.9 at start of programme to 322.37 recently. However, an analysis of indirect factors impacting on adherence point to placing increased attention on strengthening health systems and finding creative solutions to improve adherence. This should be aimed at both health care facilities as well as support networks within communities.
It calls for coordinated efforts from other actors, especially those experienced in chronic care models. If the SA government is aiming at scaling up access to the 1.4 million people that need treatment by 2009, issues of adherence and current lessons need to be addressed urgently to prevent long term treatment failure and future drug resistance.
Related Research Outputs:
- New insights into HIV epidemic in South Africa: key findings from the National HIV Prevalence, Incidence and Behaviour Survey, 2012
- Development of HIV behavioural risk reduction intervention programmes for people living with HIV/AIDS in support groups
- Sugar daddies' and HIV: is it really about money, money, money?
- Review of behavioural interventions and strategies for changing HIV-related behaviours
- The feasibility of implementing a sexual risk reduction intervention in routine clinical practice at an ARV clinic in Cape Town: results of a pilot study
- Innovative mobilization strategies for attracting at risk youth and young adults to participate in community-based voluntary counselling and testing in rural Kwa-Zulu Natal, South Africa (Project Accept - HPTN 043)
- HIV and youth: a behavioural perspective
- Positive prevention: HIV risk reduction for people living with HIV/AIDS
- The feasibility of implementing a sexual risk reduction intervention in routine clinical practice at an ARV clinic in Cape Town: a case study
- Challenges faced by people living with HIV/AIDS in Cape Town, South Africa: issues for group risk reduction interventions
- Lay counsellor-based risk reduction intervention with HIV positive diagnosed patients at public HIV counselling and testing sites in Mpumalanga, South Africa
- Are HIV positive women who have sex with women (WSW) an unrecognized and neglected HIV risk group in South Africa?
- Abstinence among SA youth: is there buy-in?
- HIV knowledge, risk perception and risk behaviour among male ex-offenders in Mpumalanga, South Africa
- The significance of understanding social scripting of sexual encounters, diverse sexual cultures and sub-cultures in developing HIV prevention programs relevant to South African women
- A community-based study to examine the effect of a youth HIV prevention programme in South Africa
- Integrated strategies for combination HIV prevention: principles and examples for men who have sex with men in the Americas and heterosexual African populations
- HIV testing is associated with increased knowledge and reductions in sexual risk behaviours among men in Cape Town, South Africa
- Comprehensive HIV prevention package for MSM in southern Africa: pilot study: Phase III of the Sibanye Health Project
- Comprehensive HIV prevention package for MSM in southern Africa: pilot study: the Sibanye Health Project